Bioventus Inc - Class A (BVS) Company Profile & Statistics

Bioventus Inc - Class A
BVS
(Nasdaq - US)
Closed
11.72
+0.21 (+1.82%)
in:usd•As of: Nov 22, 2024 15:59 UTC -5
Open
11.55
High
11.89
Low
11.38

About Bioventus Inc - Class A

CEO

Robert E. Claypoole

Headquarters

4721 emperor boulevard, suite 100

durham, nc 27703, united states

Auditor

GRANT THORNTON LLP

Employees

970

Share Holders

N/A

Website

http://www.bioventus.com

Industry

medical specialties

Sector

health technology

Company Overview

Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.

Bioventus Inc - Class A Statistics

Valuation Measures

Market Capitalization ²	912.18M
Enterprise Value	1.25B
Enterprise Value/EBITDA (ttm)	40.65
Price to Earnings Ratio (ttm)	29.72
Price to Book (mrq)	5.03
Price to Sales (ttm)	1.69
Price to Cash (ytd)	14.65

Profitability

Gross Margin (ttm)	66.96%
Operating Margin (ttm)	5.73%
Profit Margin (ttm)	-6.84%
Return on Equity (ttm)	15.61%
Return on Invested Capital (ttm)	-9.38%
Return on Assets (ttm)	4.01%

Income Statement

Revenue (ttm)	555.06M
Revenue Per Share (ttm)	6.84
Gross Profit (ttm)	371.87M
EBITDA (ttm)³	30.81M
Net Income Avi to Common (ttm)	-39.48M
Diluted EPS (ttm)	-0.61

Share Statistics

Beta (5Y Monthly)	0.88
52-Week Change	203.63%
S&P500 52-Week Change	31.00%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	81.15M
Dividend Yield	0.00%
Float ⁴	54.45M
% Held by Insiders	32.90%
% Held by Institutions	62.94%

Balance Sheet

Total Cash (mrq)	43.07M
Total Cash Per Share (mrq)	0.53
Total Debt (mrq)	383.59M
Total Debt/Equity (mrq)	205.31%
Current Ratio (mrq)	1.41%
Quick Ratio (mrq)	0.99%
Book Value Per Share (mrq)	2.30

Cash Flow

Operating Cash Flow Per Share (ytd)	0.30
Free Cash Flow (ytd)	19.04M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Bioventus Inc - Class A

Trade With A Regulated Broker